SEC 13F Intelligence

Managers / Q1 2026

Dauntless Investment Group, LLC

CIK 0002044285 · 3283 FOXFIRE DR., MILFORD, MI, 48380 · 734-770-0040

Reported Value
$151M
Q1 2026
Positions
69
Filings on Record
6
2019–present window
Filed
May 14, 2026
original filing

Summary

Dauntless Investment Group, LLC reported $151M in U.S.-listed holdings across 69 positions for Q1 2026.

Its largest position, INVA, represents 1.9% of the portfolio.

Compared with Q4 2025, the fund opened 33 new positions and exited 27.

Portfolio Metrics

Turnover
+75.1%
vs prior filed quarter
Top-10 Concentration
+13.4%
share of reported value
Largest Position
+1.9%
Innoviva
New / Exited
33 / 27
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’24: $95MQ4 ’24Q1 ’25: $85MQ1 ’25Q2 ’25: $58MQ2 ’25Q3 ’25: $160MQ3 ’25Q4 ’25: $126MQ4 ’25Q1 ’26: $151MQ1 ’26filingsflow.com

Portfolio Composition

By security type
ETP: 74.3%Common Stock: 17.7%Other: 6.0%ADR: 1.5%MLP: 0.5%Other: 0.0%
  • ETP · 74.3% · $112M
  • Common Stock · 17.7% · $27M
  • Other · 6.0% · $9M
  • ADR · 1.5% · $2M
  • MLP · 0.5% · $725,426
  • Other · 0.0% · $5,316

Quarter-over-Quarter Changes full breakdown →

vs Q4 2025 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
ISHARES TRNEW+824.7K824.7K+$79M$79M
SELECT SECTOR SPDR TRNEW+78.0K78.0K+$9M$9M
ISHARES TRNEW+28.4K28.4K+$7M$7M
TOITHE ONCOLOGY INSTITUTE INCNEW+462.1K462.1K+$1M$1M
TROWPRICE T ROWE GROUP INCNEW+14.8K14.8K+$1M$1M
QNRXQUOIN PHARMACEUTICALS LTDNEW+196.6K196.6K+$1M$1M
PPCPILGRIMS PRIDE CORPNEW+31.4K31.4K+$1M$1M
CALMCAL MAINE FOODS INCNEW+14.2K14.2K+$1M$1M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2026

42 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1INVAINNOVIVA INChistory →COM1.89%$3M122.4K
2FEMASYS INCCOM1.68%$3M6.03M
3TIZIANA LIFE SCIENCES LTDCOMMON SHARES1.68%$3M2.17M
4AEONAEON BIOPHARMA INChistory →CL A NEW1.65%$2M2.53M
5LINCLINCOLN EDL SVCS CORPhistory →COM1.60%$2M59.4K
6JOEST JOE COhistory →COM1.34%$2M32.3K
7PRNPROFOUND MED CORPhistory →COM NEW1.03%$2M240.7K
8TOITHE ONCOLOGY INSTITUTE INCCOM0.94%$1M462.1K
9QNRXQUOIN PHARMACEUTICALS LTDSPONSORED ADS0.86%$1M196.6K
10PPCPILGRIMS PRIDE CORPCOM0.78%$1M31.4K
11CALMCAL MAINE FOODS INCCOM NEW0.75%$1M14.2K
12MPCMARATHON PETE CORPCOM0.67%$1M4.2K
13UNCYUNICYCIVE THERAPEUTICS INCCOM NEW0.64%$967,832147.1K
14ARMPARMATA PHARMACEUTICALS INCCOM0.61%$927,53990.6K
15MAREX GROUP PLCORD0.60%$905,95520.3K
16TRAWTRAWS PHARMA INCCOM NEW0.51%$763,106417.0K
17KZIAKAZIA THERAPEUTICS LTDSPONSORED ADS0.39%$593,95079.8K
18PTCTPTC THERAPEUTICS INCCOM0.38%$569,7038.4K
19ESTABLISHMENT LABS HLDGS INCCOM0.35%$535,3229.4K
20UTIUNIVERSAL TECHNICAL INST INCCOM0.35%$526,37414.6K
21COURCOURSERA INCCOM0.34%$513,16188.2K
22COPA HOLDINGS SACL A0.32%$488,9774.3K
23DOLE PLCORD SHS0.31%$471,75633.0K
24CAPRCAPRICOR THERAPEUTICS INCCOM NEW0.28%$427,72814.1K
25STIMNEURONETICS INCCOM0.26%$390,352269.2K
26XP INCCL A0.25%$384,15120.2K
27JBS N.V.CL A SHS0.25%$382,69221.3K
28EKSO BIONICS HLDGS INCCOM NEW0.25%$378,00035.5K
29CRISEURCURIS INCCOM0.24%$362,299658.7K
30DCDAKOTA GOLD CORPCOM0.23%$348,65769.0K
31CGTXCOGNITION THERAPEUTICS INCCOM0.22%$327,345431.0K
32TLPHTALPHERA INCCOM NEW0.22%$325,076435.2K
33AC IMMUNE SASHS0.20%$295,595107.5K
34MPLXMPLX LPCOM UNIT REP LTD0.20%$295,0525.2K
35FUTUFUTU HLDGS LTDSPON ADS CL A0.17%$253,5531.9K
36ETENERGY TRANSFER EQUITY L PCOM UT LTD PTN0.16%$237,39012.3K
37INMBINMUNE BIO INCCOM0.14%$207,328183.5K
38VSTMVERASTEM INCCOM NEW0.13%$194,77536.8K
39EPDENTERPRISE PRODS PARTNERS LCOM0.13%$192,9845.1K
40VITLVITAL FARMS INCCOM0.11%$163,83411.6K
41ADAGADAGENE INCADS0.09%$136,31834.8K
42CHRSCOHERUS BIOSCIENCES INCCOM0.09%$128,58776.1K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$151M69May 14, 202613F-HRchanges · EDGAR ↗
Q4 2025$126M71Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$160M65Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$58M69Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$85M56May 7, 202513F-HRchanges · EDGAR ↗
Q4 2024$95M62Feb 14, 202513F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.